SeaStar Medical Statistics Share Statistics SeaStar Medical has 27.91M
shares outstanding. The number of shares has increased by 525.45%
in one year.
Shares Outstanding 27.91M Shares Change (YoY) 525.45% Shares Change (QoQ) 72.96% Owned by Institutions (%) 0% Shares Floating 27.65M Failed to Deliver (FTD) Shares 26,480 FTD / Avg. Volume 0.76%
Short Selling Information The latest short interest is 4.47M, so 16.02% of the outstanding
shares have been sold short.
Short Interest 4.47M Short % of Shares Out 16.02% Short % of Float 16.09% Short Ratio (days to cover) 4.17
Valuation Ratios The PE ratio is -0.29 and the forward
PE ratio is -1.52.
SeaStar Medical's PEG ratio is
0.
PE Ratio -0.29 Forward PE -1.52 PS Ratio 53.8 Forward PS 9 PB Ratio -3.33 P/FCF Ratio -0.45 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for SeaStar Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.55,
with a Debt / Equity ratio of -0.26.
Current Ratio 0.55 Quick Ratio 0.55 Debt / Equity -0.26 Debt / EBITDA -0.02 Debt / FCF -0.04 Interest Coverage -73.12
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $7.11K Profits Per Employee $-1.31M Employee Count 19 Asset Turnover 0.03 Inventory Turnover n/a
Taxes Income Tax 3K Effective Tax Rate -0.01%
Stock Price Statistics The stock price has increased by -84.81% in the
last 52 weeks. The beta is -1.04, so SeaStar Medical's
price volatility has been lower than the market average.
Beta -1.04 52-Week Price Change -84.81% 50-Day Moving Average 0.81 200-Day Moving Average 1.29 Relative Strength Index (RSI) 42.1 Average Volume (20 Days) 3,477,207
Income Statement In the last 12 months, SeaStar Medical had revenue of 135K
and earned -24.83M
in profits. Earnings per share was -6.63.
Revenue 135K Gross Profit 135K Operating Income -17.84M Net Income -24.83M EBITDA -24.58M EBIT -24.58M Earnings Per Share (EPS) -6.63
Full Income Statement Balance Sheet The company has 1.82M in cash and 574K in
debt, giving a net cash position of 1.25M.
Cash & Cash Equivalents 1.82M Total Debt 574K Net Cash 1.25M Retained Earnings -139.56M Total Assets 8.38M Working Capital 2.6M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -16.01M
and capital expenditures 0, giving a free cash flow of -16.01M.
Operating Cash Flow -16.01M Capital Expenditures n/a Free Cash Flow -16.01M FCF Per Share -4.28
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -13216.3% and -18392.59%.
Gross Margin 100% Operating Margin -13216.3% Pretax Margin -18390.37% Profit Margin -18392.59% EBITDA Margin -18209.63% EBIT Margin -13216.3% FCF Margin -11857.04%
Dividends & Yields ICU does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ICU.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 10, 2024. It was a
backward
split with a ratio of 1:25.
Last Split Date Jun 10, 2024 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -27.35 Piotroski F-Score 3
